{
    "url_original": "https://www.wsj.com/articles/pfizer-asks-fda-to-authorize-covid-19-pill-paxlovid-11637089791?mod=politics_lead_pos11",
    "url": "pfizer-asks-fda-to-authorize-covid-19-pill-paxlovid-11637089791",
    "title": "Pfizer Submits Covid-19 Pill for FDA Authorization",
    "sub_head": "Testing found pill 89% effective at reducing risk of hospitalization and death from Covid-19 when taken soon after diagnosis",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-11-16 15:42:00",
    "body": "Pfizer Inc.  said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting the pill on a path that could make it available for people to take at home by the end of the year.<br />Clearance from the U.S. Food and Drug Administration would give patients and doctors an easy-to-use treatment to keep people out of the hospital early in the course of the disease."
}